FluoLink delivers a fully functioning prototype and probes for identification of malignant brain tumour during biopsy and resection.
FluoLink's solution minimizes the risk of bleeding in the brain by avoiding larger blood vessels crossing the intended path for the probe.
In comparison to conventional technology, this creates higher precision, better risk control and higher efficiency for the patient, the neurosurgeon, and the clinical institution through safe distinction between tumorous and healthy brain tissue.